Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer

Fig. 3

The results of real-time PCR in HCT-116 and HT-29 cell lines after 24 and 48 h of drug treatment. SFN and SOX4 expression tezacaftor treatment on the HCT-116 (A) and HT-29 (B). Cdh1 and Twist1 expression of bempedoic acid treatment on the HCT-116 (C) and HT-29 (D). BAD and STMN1 expression of Fenticonazole treatment on the HCT-116 (E) and HT-29 (F). MMP1 expression of famciclovir treatment on the HCT-116 (G) and HT-29 (H). *, ** and ***Symbol denotes significance at P < 0.05, 0.01 and 0.001 levels

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us